The industry needs scientific data to develop intelligently, and that can’t happen until political and professional biases are uprooted.
Recreational cannabis markets are opening up across North America. Yet restrictions on university cannabis research remain. They prevent consumers, patients, medical professionals, the cannabis industry and policy-makers from making decisions based on scientific data.
There are numerous barriers to conducting research on cannabis, especially in countries where cannabis is illegal. But even in Canada, where cannabis was legalized in 2018, such barriers persist and include stringent restrictions on partnerships between the cannabis industry and researchers. We think these restrictions require a second look, as they are hampering governments from meeting their own policy objectives. Preserving public health and public safety while also promoting social justice and economic development requires strong partnerships among governments, universities and industry.
Read the full article at FOLIO